Canine Genomics: $200M Funded to Create Engineered Military Canines

The first generation of genetically modified dogs intended for military service is scheduled to arrive in early 2027. This milestone marks the practical application of a $200 million investment secured by a new venture named Warhound. The company was established to develop canines with specific biological advantages and to equip them with specialized hardware for use by the United States armed forces.

The biological foundation for these animals comes from a carefully selected pool of donor cells. Warhound has already begun the process of editing genetic material obtained from top-performing working dogs. These samples were sourced from animals that have served in military, police, and first responder roles across the country. The majority of the donor pool consists of Belgian Malinois, with a smaller number of labradors and shepherds included to ensure genetic diversity.

Scientists affiliated with Colossal Biosciences are tasked with the genetic modification and subsequent cloning of these animals. The primary objective of this initial phase is to mitigate common health issues that affect these breeds. Specifically, the team aims to reduce the likelihood of hip dysplasia and certain types of cancer. While the current focus is on health, company leadership has indicated that future iterations could include enhancements to speed, agility, and olfactory sensitivity.

The project brings together two prominent figures from the technology sector. Palmer Luckey, known for founding Oculus VR and designing the Rift headset, is a partner in the business. His defense firm, Anduril, has previously worked with OpenAI on artificial intelligence projects for the Pentagon and recently secured a contract with the US Army for battlefield intelligence systems. His co-founder, Ben Lamm, leads Colossal Biosciences, a company recognized for its work in de-extinction, including efforts to revive the dire wolf and the woolly mammoth.

Anduril’s contribution to the project is centered on the equipment the dogs will wear rather than their biological makeup. The company is not planning to create cyborg canines at this stage. Instead, its engineers are designing protective gear, such as goggles, vests, and body armor, along with the software that controls these devices. This approach ensures the animals are protected while performing their duties in the field.

The corporate structure of the venture differs slightly from the public perception of the partnership. While Luckey is involved as a partner, neither he nor Anduril holds a financial stake in the startup. Equity in the company is held by Colossal Biosciences, and Lamm serves on the board of directors. The day-to-day operations are led by CEO David Spirk, who previously worked at Palantir.

Once born, the first batch of these engineered dogs will undergo training for standard working roles. Their duties will mirror those of current service dogs, including bomb detection and assistance in search-and-rescue missions. The timing of their arrival places the project on a steady track toward integration into defense operations within the next year.